These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3039766)

  • 1. Effects of fludrocortisone withdrawal on plasma angiotensin II, ACTH, vasopressin, and potassium in patients with Addison's disease.
    Oelkers W; Bähr V
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):325-30. PubMed ID: 3039766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA; Livesey JH; Florkowski C; Or HK; Donald RA; Espiner EA
    J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone.
    Oelkers W; Diederich S; Bähr V
    J Clin Endocrinol Metab; 1992 Jul; 75(1):259-64. PubMed ID: 1320051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of mineralocorticoid substitution in Addison's disease by plasma renin measurement.
    Oelkers W; L'age M
    Klin Wochenschr; 1976 Jul; 54(13):607-12. PubMed ID: 940296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid replacement in Addison's disease.
    Thompson DG; Mason AS; Goodwin FJ
    Clin Endocrinol (Oxf); 1979 May; 10(5):499-506. PubMed ID: 476980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin II on plasma ACTH in patients with Addison's disease.
    Haller H; Bähr V; Exner P; Oelkers W
    Acta Endocrinol (Copenh); 1985 Dec; 110(4):451-5. PubMed ID: 3004086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin II infusion on the early morning surge of ACTH and o-CRH-provoked ACTH secretion in normal man.
    Haller H; Hensen J; Bähr V; Oelkers W
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):150-6. PubMed ID: 3017033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dissociation of renin and aldosterone during critical illness.
    Findling JW; Waters VO; Raff H
    J Clin Endocrinol Metab; 1987 Mar; 64(3):592-5. PubMed ID: 3029157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
    Cohen N; Gilbert R; Wirth A; Casley D; Jerums G
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1411-5. PubMed ID: 8636343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that patients with Addison's disease are undertreated with fludrocortisone.
    Smith SJ; MacGregor GA; Markandu ND; Bayliss J; Banks RA; Prentice MG; Dorrington-Ward P; Wise P
    Lancet; 1984 Jan; 1(8367):11-4. PubMed ID: 6140341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin, angiotensin, corticosteroids, and electrolyte balance in Addison's disease.
    Brown JJ; Fraser R; Lever AF; Robertson JI; James VH; McCusker J; Wynn V
    Q J Med; 1968 Jan; 37(145):97-118. PubMed ID: 4297956
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of furosemide and ACTH on plasma renin, aldosterone and cortisol levels in normal man].
    Cénac A; London A; Ménard J; Corvol P
    Ann Endocrinol (Paris); 1975; 36(3):153-62. PubMed ID: 172005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of adrenocorticotropin in the cortisol and aldosterone responses to angiotensin II in conscious dogs.
    Brooks VL; Daneshvar L; Reid IA
    Endocrinology; 1988 Jan; 122(1):97-104. PubMed ID: 2826116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement.
    Feek CM; Ratcliffe JG; Seth J; Gray CE; Toft AD; Irvine WJ
    Clin Endocrinol (Oxf); 1981 May; 14(5):451-8. PubMed ID: 6273020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiated hormonal responses in a model of traumatic injury.
    DeMaria EJ; Lilly MP; Gann DS
    J Surg Res; 1987 Jul; 43(1):45-51. PubMed ID: 3037194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH-releasing peptide (GHRP-6)-induced ACTH release in patients with addison's disease: effect of glucocorticoid withdrawal.
    Martins MR; Pinto AC; Brunner E; Silva MR; Lengyel AM
    J Endocrinol Invest; 2003 Feb; 26(2):143-7. PubMed ID: 12739742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How should the plasma ACTH level in treated Addison's disease patients be interpreted?].
    Pehuet-Figoni M; Bertagna X; Girard F; Bricaire H; Luton JP
    Ann Endocrinol (Paris); 1989; 50(1):54-7. PubMed ID: 2543260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addison's Disease and Pituitary Enlargement.
    Winters SJ; Vitaz T; Nowacki MR; Craddock DC; Silverman C
    Am J Med Sci; 2015 Jun; 349(6):526-9. PubMed ID: 25004119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
    Shoback DM; Williams GH; Hollenberg NK; Davies RO; Moore TJ; Dluhy RG
    J Clin Endocrinol Metab; 1983 Oct; 57(4):764-70. PubMed ID: 6309884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of aldosterone biosynthesis during sodium deficiency. Evidence for an essential role of the pituitary gland.
    McCaa RE; Langford HG; Montalvo JM; Andy OJ; Read VH; McCaa CS
    Hypertension; 1981; 3(3 Pt 2):I74-80. PubMed ID: 6266960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.